Risk factors for late recurrent candidaemia. A retrospective matched case-control study

被引:34
作者
Munoz, P. [1 ,2 ,3 ,4 ]
Vena, A. [1 ,2 ,4 ]
Valerio, M. [1 ]
Alvarez-Uria, A. [1 ]
Guinea, J. [1 ]
Escribano, P. [1 ]
Bouza, E. [1 ,2 ,3 ,4 ]
机构
[1] Hosp Gen Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain
[2] Hosp Gregorio Maranon Gen Univ, Inst Invest Sanitaria, Madrid, Spain
[3] Univ Complutense Madrid, CIBER Enfermedades Resp CIBERES, CB06-06-0058, Madrid, Spain
[4] Univ Complutense Madrid, Sch Med, Dept Med, Madrid, Spain
关键词
Candida endocarditis; candidaemia; candidiasis; invasive disease; recurrent infection; BREAKTHROUGH BACTEREMIA; PNEUMOCOCCAL BACTEREMIA; MOLECULAR EPIDEMIOLOGY; CANDIDEMIA; EPISODES; FUNGEMIA; INFECTIONS; PERSISTENT; MANAGEMENT; GLABRATA;
D O I
10.1016/j.cmi.2015.10.023
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Incidence, risk factors and clinical significance of late recurrent (LR) candidaemia (>1 month between episodes) remains unclear. The 1219 episodes of candidaemia detected from January 1985 to December 2014 were reviewed. We selected all cases with more than one episode separated by at least 30 days after clinical resolution in the interim (cases) and compared each of them with two controls (patients with single episodes of candidaemia). Clinical strains were genotyped to differentiate relapses from re-infection. Eighteen patients (1.48%) had 36 episodes of LR candidaemia (median 4 months). Independent risk factors for recurrence in the multivariate analysis were: underlying gastrointestinal disease (OR 67.16; 95% CI 5.23-861.71; p0.001) and fungaemia due to Candida parapsilosis (OR 9.10; 95% 1.33-62.00; p 0.02). All episodes of LR candidaemia diagnosed during the first 3 months were due to an intravascular source of infection, whereas in those occurring after 3 months the main source of the disease was the abdomen, followed by endocarditis, and urinary tract. Molecular typing showed that 42.9% of LR candidaemias were relapses and 57.1% were re-infections. Neither time of recurrence nor clinical origin could predict type of recurrence. LR candidaemia is a relatively rare event that is more frequent in patients who have an initial episode of candidaemia due to C. parapsilosis or an underlying gastrointestinal disease. Episodes of LR candidaemia that occur within the first 3 months should prompt an attempt to exclude an intravascular source of infection, whereas those occurring later point to an intraabdominal origin. (C) 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
引用
收藏
页码:277.e11 / 277.e20
页数:10
相关论文
共 35 条
[1]   Recurrent gram-negative bloodstream infection: A 10-year population-based cohort study [J].
Al-Hasan, Majdi N. ;
Eckel-Passow, Jeanette E. ;
Baddour, Larry M. .
JOURNAL OF INFECTION, 2010, 61 (01) :28-33
[2]   Molecular epidemiology of late recurrent candidaemiaua population-based study in Iceland [J].
Asmundsdottir, L. R. ;
Erlendsdottir, H. ;
Gisladottir, A. L. ;
Gottfredsson, M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (02) :195-201
[3]   Recurrent vancomycin-resistant Enterococcus bacteremia:: Prevalence, predisposing factors, and strain relatedness [J].
Baran, J ;
Riederer, KM ;
Ramanathan, J ;
Khatib, R .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1381-1383
[4]   Analysis of microsatellite markers of Candida albicans used for rapid typing [J].
Botterel, F ;
Desterke, C ;
Costa, C ;
Bretagne, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) :4076-4081
[5]   INCIDENCE AND RISK-FACTORS OF RECURRENT EPISODES OF BACTEREMIA IN ADULTS [J].
CAPDEVILA, JA ;
ALMIRANTE, B ;
PAHISSA, A ;
PLANES, AM ;
RIBERA, E ;
MARTINEZVAZQUEZ, J .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (04) :411-415
[6]   Staphylococcus aureus bacteremia -: Recurrence and the impact of antibiotic treatment in a prospective multicenter study [J].
Chang, FY ;
Peacock, JE ;
Musher, DM ;
Triplett, P ;
MacDonald, BB ;
Mylotte, JM ;
O'Donnell, A ;
Wagener, MM ;
Yu, VL .
MEDICINE, 2003, 82 (05) :333-339
[7]   Clinical manifestations and molecular epidemiology of late recurrent candidemia, and implications for management [J].
Clancy, CJ ;
Barchiesi, F ;
DiFrancesco, LF ;
Morris, AJ ;
Snydman, DR ;
Yu, VL ;
Scalise, G ;
Nguyen, MH .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (08) :585-592
[8]   Multilocus sequence typing of sequential Candida albicans isolates from patients with persistent or recurrent fungemia [J].
Da Matta, Daniel A. ;
Melo, Analy S. ;
Guimaraes, Thais ;
Frade, Joao P. ;
Lott, Timothy J. ;
Colombo, Arnaldo L. .
MEDICAL MYCOLOGY, 2010, 48 (05) :757-762
[9]   Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes [J].
Dupla, ML ;
Martinez, JA ;
Vidal, F ;
Almela, M ;
Lopez, J ;
Marco, F ;
Soriano, A ;
Richart, C ;
Mensa, J .
JOURNAL OF INTERNAL MEDICINE, 2005, 258 (02) :172-180
[10]  
Font B, 2001, EUR J CLIN MICROBIOL, V20, P636